TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
International Journal of Molecular Sciences · 29.04.2023 · 24 (9) · 8065
DOI: 10.3390/ijms24098065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.04.2023. Verfasst von Stefania Mantovani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Division of Clinical Immunology-Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, COVID-19. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (INF-ACT)., Next Generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been responsible for a devastating pandemic since March 2020. Toll-like receptors (TLRs), crucial components in the initiation of innate immune responses to different pathogens, trigger the downstream production of pro-inflammatory cytokines, interferons, and other mediators. It has been demonstrated that they contribute to the dysregulated immune response observed in patients with severe COVID-19. TLR2, TLR3, TLR4 and TLR7 have been associated with COVID-19 severity. Here, we review the role of TLRs in the etiology and pathogenesis of COVID-19, including TLR7 and TLR3 rare variants, the L412F polymorphism in TLR3 that negatively regulates anti-SARS-CoV-2 immune responses, the TLR3-related cellular senescence, the interaction of TLR2 and TLR4 with SARS-CoV-2 proteins and implication of TLR2 in NET formation by SARS-CoV-2. The activation of TLRs contributes to viral clearance and disease resolution. However, TLRs may represent a double-edged sword which may elicit dysregulated immune signaling, leading to the production of proinflammatory mediators, resulting in severe disease. TLR-dependent excessive inflammation and TLR-dependent antiviral response may tip the balance towards the former or the latter, altering the equilibrium that drives the severity of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research, Division of Clinical Immunology-Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
- Medical Genetics, University of Siena, 53100 Siena, Italy.
- Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
- Genetica Medica, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
ORCID-Profile: Stefania Mantovani, Stefania Varchetta, Alessandra Renieri, Mario U Mondelli
Förderung
- Next Generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (INF-ACT).
- Next Generation EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Mantovani, S., Oliviero, B., Varchetta, S., Renieri, A., & Mondelli, M. U. (2023). TLRs: Innate Immune Sentries against SARS-CoV-2 Infection. International Journal of Molecular Sciences, 24(9), 8065. https://doi.org/10.3390/ijms24098065
Vancouver
Mantovani S, Oliviero B, Varchetta S, Renieri A, Mondelli MU. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection. International Journal of Molecular Sciences. 2023;24(9):8065. doi:10.3390/ijms24098065
BibTeX
@article{Mantovani2023,
author = {Mantovani, Stefania and Oliviero, Barbara and Varchetta, Stefania and Renieri, Alessandra and Mondelli, Mario U},
title = {TLRs: Innate Immune Sentries against SARS-CoV-2 Infection},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {8065},
doi = {10.3390/ijms24098065}
}
EUVIMED